 pBABE- Puro |
|||
| PVT11054 | Lifescience Market | 2 ug | EUR 301 |
 pBABE-Puro-HA-Brca1 |
|||
| PVT17834 | Lifescience Market | 2 ug | EUR 424 |
 pBABE-Puro-Sam68 Plasmid |
|||
| PVTB00471-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE-Puro-ARHGEF4 Plasmid |
|||
| PVTB00766-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE-Puro-CNOT1 Plasmid |
|||
| PVTB00869-2a | Lifescience Market | 2 ug | EUR 356 |
 pBABE-Puro-PPP2R5A Plasmid |
|||
| PVTB01072-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE puro-EGFP Plasmid |
|||
| PVTB80003-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE- Puro SV40 LT |
|||
| PVT10529 | Lifescience Market | 2 ug | EUR 301 |
 pBABE-Puro-hTERT Retroviral Vector |
|||
| RTV-006 | Cell Biolabs | 100 µL | EUR 717 |
|
Description: Use this gene-specific construct for downstream recombinant retroviral packaging |
|||
 pBABE-Puro-hTID-1 Plasmid |
|||
| PVTB00190-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE-Puro-KIFAP3-HA Plasmid |
|||
| PVTB01071-4b | Lifescience Market | 2 ug | EUR 356 |
 pBABE-Puro-AP-2 Plasmid |
|||
| PVTB01073-4a | Lifescience Market | 2 ug | EUR 356 |
 HA- HIF1alpha- wt- pBabe- puro |
|||
| PVT10257 | Lifescience Market | 2 ug | EUR 301 |
 pBABE-puro mCherry-EGFP-LC3B |
|||
| PVT14018 | Lifescience Market | 2 ug | EUR 911 |
 Plasmid) pBABE-Puro-IQGAP1(1503-1657aa) Plasmid |
|||
| PVTB01069-4a | Lifescience Market | 2 ug | EUR 356 |
 Plasmid) pBABE-Puro-Striatin(366-731aa) Plasmid |
|||
| PVTB01070-4a | Lifescience Market | 2 ug | EUR 356 |
 Plasmid) pBABE-Puro-KIFAP3(606-772aa) Plasmid |
|||
| PVTB01071-4a | Lifescience Market | 2 ug | EUR 356 |
 Plasmid) pBABE-Puro-AMER1(716-834aa) Plasmid |
|||
| PVTB01079-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE- hLin28B |
|||
| PVT10399 | Lifescience Market | 2 ug | EUR 301 |
 pBABE GFP |
|||
| PVT11055 | Lifescience Market | 2 ug | EUR 266 |
) HEK293-TetR (Puro) |
|||
| SC005-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1210 |
|
Description: tetracycline repressor in HEK293 stable cell line with Puromycin fusion marker |
|||
 lentivirus) hTERT (CMV, Puro) lentivirus |
|||
| LVP1130-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 349 |
|
Description: Premade lentivirus expressing human TERT gene under suCMV promoter, containing Puromycin marker. |
|||
 lentivirus) hTERT (EF1a, Puro) lentivirus |
|||
| LVP1131-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 349 |
|
Description: Premade lentivirus expressing human TERT gene under EF1a promoter, containing Puromycin marker. |
|||
 , Lentiviral particles) rtTA (Puro) , Lentiviral particles |
|||
| LVP400-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 404 |
|
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Puromycin antibioic marker, provided in DMEM medium with 10% FBS. |
|||
 pBABE-Hygro-3 |
|||
| PVT17647 | Lifescience Market | 2 ug | EUR 258 |
) pBabe EGFR(T790M) |
|||
| PVT17710 | Lifescience Market | 2 ug | EUR 341 |
 pBabe EGFR Del1 |
|||
| PVT17718 | Lifescience Market | 2 ug | EUR 341 |
 pBABE- neo- hTERT |
|||
| PVT10354 | Lifescience Market | 2 ug | EUR 301 |
 pBABE- neo- largeTcDNA |
|||
| PVT11100 | Lifescience Market | 2 ug | EUR 301 |
 pBABE-hygro-hTERT |
|||
| PVT17568 | Lifescience Market | 2 ug | EUR 341 |
 Lentiviral particles ) CMV-TetR (Puro) Lentiviral particles |
|||
| LVP017-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 404 |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Puromycin antibiotic marker. |
|||
 lentiviral particles) β-Lactamase (Puro) lentiviral particles |
|||
| LVP335-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 349 |
|
Description: pre-made lentiviral particles expressing β-Lactamase gene. A puromycin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
 Lentiviral particles ) EF1a-TetR (Puro) Lentiviral particles |
|||
| LVP459-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 404 |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Puromycin antibioic marker. |
|||
 stable cells) Hela-TetR (Puro) stable cells |
|||
| SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1210 |
|
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
|||
 lentivirus) LoxP GFP/RFP ColorSwitch (Puro) lentivirus |
|||
| LVP460-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 710 |
|
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a puromycin antibiotic selection marker under Rsv promoter. Virus is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
, CMV lentiviral particles) SV40 large T-antigen (Puro), CMV lentiviral particles |
|||
| LVP016-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 349 |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing puromycin marker. |
|||
, EF1a lentiviral particles) SV40 large T-antigen (Puro), EF1a lentiviral particles |
|||
| LVP557-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 349 |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under EF1a promoter, containing puromycin marker. |
|||
 Stable Cell Line) MDA-MB-231 / GFP (Puro) Stable Cell Line |
|||
| SC040-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1210 |
|
Description: GFP expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|||
 Stable Cell Line) MDA-MB-231 / Luciferase (Puro) Stable Cell Line |
|||
| SC059-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1500 |
|
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|||
 pBABE-Hygro Retroviral Vector |
|||
| RTV-001-HYGRO | Cell Biolabs | 10 ?g | EUR 566 |
|
Description: Use this construct to clone your gene for downstream recombinant retroviral packaging |
|||
 pBABE-GFP Retroviral Vector |
|||
| RTV-002 | Cell Biolabs | 10 ?g | EUR 717 |
|
Description: Use this gene-specific construct for downstream recombinant retroviral packaging |
|||
 pBABE-Neo Retroviral Vector |
|||
| RTV-003 | Cell Biolabs | 100 µL | EUR 566 |
|
Description: Use this construct to clone your gene for downstream recombinant retroviral packaging |
|||
 pBABE-Zeo Retroviral Vector |
|||
| RTV-004 | Cell Biolabs | 100 µL | EUR 566 |
|
Description: Use this construct to clone your gene for downstream recombinant retroviral packaging |
|||
) pBabe EGFR(L858R-T790M) |
|||
| PVT17709 | Lifescience Market | 2 ug | EUR 341 |
 Plasmid) pBABE-CX3CR1(L355H) Plasmid |
|||
| PVTB00410-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE-mIFITM1-EGFP Plasmid |
|||
| PVTB50031-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE-mIFITM2-EGFP Plasmid |
|||
| PVTB50032-4a | Lifescience Market | 2 ug | EUR 356 |
 pBABE-mIFITM3-EGFP Plasmid |
|||
| PVTB50033-4a | Lifescience Market | 2 ug | EUR 356 |
 pBabe-hygro PyMT Plasmid |
|||
| PVT14778 | Lifescience Market | 2 ug | EUR 325 |
 pBabe-HA-ER-IPpoI |
|||
| PVT17437 | Lifescience Market | 2 ug | EUR 300 |
) Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro) |
|||
| SC018-Puro | GenTarget | 2x10E6 cell/ml x1ml | EUR 4400 |
|
Description: CRE reporter cell line (Puro): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Puromycin antibiotic marker |
|||
 pBABE-Neo-hTERT Retroviral Vector |
|||
| RTV-005 | Cell Biolabs | 100 µL | EUR 717 |
|
Description: Use this gene-specific construct for downstream recombinant retroviral packaging |
|||
 pBABE-Hygro-hTERT Retroviral Vector |
|||
| RTV-007 | Cell Biolabs | 100 µL | EUR 717 |
|
Description: Use this gene-specific construct for downstream recombinant retroviral packaging |
|||
 pBABE-3*FLAG-APC Plasmid |
|||
| PVTB00706-4a | Lifescience Market | 2 ug | EUR 356 |
) EF1a Control lentiviral particles (Puro) |
|||
| EF1a-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||